There is an encouraging amount of research being undertaken which is directed at Myositis. In Australia there are a number of clinical trials which are underway, recruiting or awaiting ethics approval. See www.anzctr.org.au for details.
Also see the website of The Myositis Association in the USA – www.myositis.org which has a list of clinical trials being conducted in the USA. Of recent importance is recruitment in the USA for a trial for a drug for treating polymyositis and dermatomyositis.
Australian Clinical Trials in brief :
1. Underway – an extension study.
An extension study of the Efficacy, Safety and Tolerability of Bimagrumab – BYM 338 on physical function, muscle strength and mobility in IBM patients who previously participated in the core study in NSW, WA and Vic.
Dysphagia (swallowing) problems in patients with myositis. Sir Charles Gardiner Hospital – Nedlands WA Contact Dr. Claire Langdon.
3. Recruiting by invitation
To explore the new form of resistance training (Kaatsu) in reducing disability caused by IBM. Sir Charles Gardiner Hospital – Nedlands WA. Contact: Mr. Dave Hawthorn 08 93462337
4. Not yet recruiting.
Pilot study prior to Phase 1 trial to study the treatment of patients with IBM with Triheptanoin. Concord hospital NSW Contact : Assoc Prof Alistair Corbett.